Skip to content

Lantheus Holdings LNTH Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Guardant Health logo
Guardant HealthGH
Revvity logo
RevvityRVTY
Labcorp Holdings logo
Labcorp HoldingsLH
Agilent Technologies logo
Agilent TechnologiesA
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Revenue$377.3M+1.2%
Gross profit$230.9M-2.9%
Operating income$81.3M-20.3%
Net income$118.4M+62.3%
EPS (diluted)$1.80+76.5%

Balance sheet

See full
Cash & equivalents$500.3M-46.8%
Total debt$627.9M+1.8%
Total equity$1.2B+4.1%
Total assets$2.3B+14.2%

Cash flow

See full
Operating cash flow$125.1M+16.3%
CapEx$3.2M-63.0%
Free cash flow$121.9M+23.3%

Valuation

See full
Market cap$6.76B-26.3%
Enterprise value$6.89B-20.5%
P/E24.2×-10.2×
P/S4.4×-1.6×

Profitability

See full
Gross margin60.5%-3.6pp
Operating margin18.8%-10.7pp
Net margin18%+0.7pp
FCF margin24.4%-6.4pp

Returns & leverage

See full
Return on equity23.5%-1.7pp
Debt / equity0.5×0.0×
Current ratio2.8×-2.9×

Where this comes from

Reported directly by Lantheus Holdings in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Lantheus Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lantheus Holdings's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lantheus Holdings's preferred stock, shares authorized?
Lantheus Holdings (LNTH) reported preferred stock, shares authorized of $25M in Q1 2026.
How has Lantheus Holdings's preferred stock, shares authorized changed year-over-year?
Lantheus Holdings's preferred stock, shares authorized decreased by 0.0% year-over-year, from $25M to $25M.
What is the long-term trend for Lantheus Holdings's preferred stock, shares authorized?
Over 5 years (2020 to 2025), Lantheus Holdings's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $25M to $25M.